284 related articles for article (PubMed ID: 33161527)
21. Adipose mesenchymal stem cell-derived exosomes accelerate skin wound healing via the lncRNA H19/miR-19b/SOX9 axis.
Qian L; Pi L; Fang BR; Meng XX
Lab Invest; 2021 Sep; 101(9):1254-1266. PubMed ID: 34045678
[TBL] [Abstract][Full Text] [Related]
22. Long non-coding RNA ASB16-AS1 enhances cell proliferation, migration and invasion via functioning as a ceRNA through miR-1305/Wnt/β-catenin axis in cervical cancer.
Liu W; Zhuang R; Feng S; Bai X; Jia Z; Kapora E; Tan W
Biomed Pharmacother; 2020 May; 125():109965. PubMed ID: 32058219
[TBL] [Abstract][Full Text] [Related]
23. LncRNA-H19 activates CDC42/PAK1 pathway to promote cell proliferation, migration and invasion by targeting miR-15b in hepatocellular carcinoma.
Zhou Y; Fan RG; Qin CL; Jia J; Wu XD; Zha WZ
Genomics; 2019 Dec; 111(6):1862-1872. PubMed ID: 30543848
[TBL] [Abstract][Full Text] [Related]
24. Long Noncoding RNA SOX2-OT Knockdown Inhibits Proliferation and Metastasis of Prostate Cancer Cells Through Modulating the miR-452-5p/HMGB3 Axis and Inactivating Wnt/β-Catenin Pathway.
Song X; Wang H; Wu J; Sun Y
Cancer Biother Radiopharm; 2020 Nov; 35(9):682-695. PubMed ID: 32407168
[No Abstract] [Full Text] [Related]
25. The lncRNA HOXA11-AS promotes glioma cell growth and metastasis by targeting miR-130a-5p/HMGB2.
Xu CH; Xiao LM; Liu Y; Chen LK; Zheng SY; Zeng EM; Li DH
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):241-252. PubMed ID: 30657566
[TBL] [Abstract][Full Text] [Related]
26. Long noncoding RNA SNHG16 contributes to the development of bladder cancer via regulating miR-98/STAT3/Wnt/β-catenin pathway axis.
Feng F; Chen A; Huang J; Xia Q; Chen Y; Jin X
J Cell Biochem; 2018 Nov; 119(11):9408-9418. PubMed ID: 30132983
[TBL] [Abstract][Full Text] [Related]
27. Long non-coding RNA H19 promotes the osteogenic differentiation of rat ectomesenchymal stem cells via Wnt/β-catenin signaling pathway.
Gong YY; Peng MY; Yin DQ; Yang YF
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8805-8813. PubMed ID: 30575922
[TBL] [Abstract][Full Text] [Related]
28. SNHG15 affects the growth of glioma microvascular endothelial cells by negatively regulating miR-153.
Ma Y; Xue Y; Liu X; Qu C; Cai H; Wang P; Li Z; Li Z; Liu Y
Oncol Rep; 2017 Nov; 38(5):3265-3277. PubMed ID: 29048682
[TBL] [Abstract][Full Text] [Related]
29. Transcription factor HIF1α promotes proliferation, migration, and invasion of cholangiocarcinoma via long noncoding RNA H19/microRNA-612/Bcl-2 axis.
Yu A; Zhao L; Kang Q; Li J; Chen K; Fu H
Transl Res; 2020 Oct; 224():26-39. PubMed ID: 32505707
[TBL] [Abstract][Full Text] [Related]
30. Long non-coding RNA H19 aggravates keloid progression by upregulating SMAD family member 5 expression via miR-196b-5p.
Li Z; Gong C; Wei H
Bioengineered; 2022 Jan; 13(1):1447-1458. PubMed ID: 34974806
[TBL] [Abstract][Full Text] [Related]
31. LncRNA H19 promotes the development of hepatitis B related hepatocellular carcinoma through regulating microRNA-22 via EMT pathway.
Li L; Han T; Liu K; Lei CG; Wang ZC; Shi GJ
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5392-5401. PubMed ID: 31298392
[TBL] [Abstract][Full Text] [Related]
32. LncRNA PART1 inhibits glioma proliferation and migration via miR-374b/SALL1 axis.
Deng YW; Shu YG; Sun SL
Neurochem Int; 2022 Jul; 157():105347. PubMed ID: 35490895
[TBL] [Abstract][Full Text] [Related]
33. The lncRNA H19 interacts with miR-140 to modulate glioma growth by targeting iASPP.
Zhao H; Peng R; Liu Q; Liu D; Du P; Yuan J; Peng G; Liao Y
Arch Biochem Biophys; 2016 Nov; 610():1-7. PubMed ID: 27693036
[TBL] [Abstract][Full Text] [Related]
34. Long non-coding RNA H19 protects against intracerebral hemorrhage injuries via regulating microRNA-106b-5p/acyl-CoA synthetase long chain family member 4 axis.
Chen B; Wang H; Lv C; Mao C; Cui Y
Bioengineered; 2021 Dec; 12(1):4004-4015. PubMed ID: 34288826
[TBL] [Abstract][Full Text] [Related]
35. Knockdown of LncRNA SCAMP1 suppressed malignant biological behaviours of glioma cells via modulating miR-499a-5p/LMX1A/NLRC5 pathway.
Zong Z; Song Y; Xue Y; Ruan X; Liu X; Yang C; Zheng J; Cao S; Li Z; Liu Y
J Cell Mol Med; 2019 Aug; 23(8):5048-5062. PubMed ID: 31207033
[TBL] [Abstract][Full Text] [Related]
36. TUG1 knockdown inhibits the tumorigenesis and progression of prostate cancer by regulating microRNA-496/Wnt/β-catenin pathway.
Li G; Yang J; Chong T; Huang Y; Liu Y; Li H
Anticancer Drugs; 2020 Jul; 31(6):592-600. PubMed ID: 32427740
[TBL] [Abstract][Full Text] [Related]
37. LncRNA H19 is overexpressed in glioma tissue, is negatively associated with patient survival, and promotes tumor growth through its derivative miR-675.
Zhang T; Wang YR; Zeng F; Cao HY; Zhou HD; Wang YJ
Eur Rev Med Pharmacol Sci; 2016 Dec; 20(23):4891-4897. PubMed ID: 27981546
[TBL] [Abstract][Full Text] [Related]
38. Long noncoding RNA papillary thyroid carcinoma susceptibility candidate 3 (PTCSC3) inhibits proliferation and invasion of glioma cells by suppressing the Wnt/β-catenin signaling pathway.
Xia S; Ji R; Zhan W
BMC Neurol; 2017 Feb; 17(1):30. PubMed ID: 28187755
[TBL] [Abstract][Full Text] [Related]
39. LncRNA-H19 inhibits apoptosis of acute myeloid leukemia cells via targeting miR-29a-3p.
Zhao TT; Liu X
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(3 Suppl):224-231. PubMed ID: 31389605
[TBL] [Abstract][Full Text] [Related]
40. The Long Noncoding RNA NEAT1 Targets miR-34a-5p and Drives Nasopharyngeal Carcinoma Progression via Wnt/β-Catenin Signaling.
Ji Y; Wang M; Li X; Cui F
Yonsei Med J; 2019 Apr; 60(4):336-345. PubMed ID: 30900419
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
